SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
Caroline Hirsch(University of Cologne), Nina Kreuzberger(University of Cologne), Lise J Estcourt(NHS Blood and Transplant), Cynthia So‐Osman(Sanquin), Maria Popp(Universitätsklinikum Würzburg), Ina Monsef(University of Cologne), Vanessa Piechotta(Robert Koch Institute), Susanne Salomon(University of Cologne), Erica M. Wood(Monash Health), E. Tomlinson(Unknown), Sarah J Valk(Leiden University Medical Center), Zoe McQuilten, David J. Roberts(NHS Blood and Transplant), Nicole Skoetz(Medical University of Vienna), Khai Li Chai(Monash University)
Cited by 19
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
SARS-CoV-2 evolution during treatment of chronic infection
|Nature|2021|1.1k
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
|The Lancet Infectious Diseases|2023|658
Patient Blood Management
|JAMA|2019|619